PFIZER BIOTECH CORPORATION

Company Profile: PFIZER BIOTECH CORPORATION

Location: Taiwan

Company Type: Factory (Manufacturer)

Business Overview:

PFIZER BIOTECH CORPORATION in Taiwan operates primarily as a manufacturing entity within the pharmaceutical and biotechnology sectors. As part of Pfizer Inc., a global biopharmaceutical company, its operations in Taiwan focus on the production, research, and development of a wide range of pharmaceutical products, including medicines and vaccines. While it also engages in the distribution of these products, its core function involves the actual production and innovation of biotechnological and pharmaceutical substances, firmly establishing it as a manufacturer rather than solely a trading company.

Pfizer Biotech Corporation in Taiwan, as a subsidiary of Pfizer Inc., primarily focuses on the distribution and commercialization of pharmaceutical products. Below are the key categories and examples of products they manage in the Taiwan market:

Vaccines

Comirnaty (COVID-19 mRNA Vaccine)

Oncology

Ibrance (Palbociclib)

Inlyta (Axitinib)

Sutent (Sunitinib)

Bosulif (Bosutinib)

Internal Medicine and Cardiovascular

Eliquis (Apixaban)

Lipitor (Atorvastatin)

Norvasc (Amlodipine)

Inflammation and Immunology

Xeljanz (Tofacitinib)

Enbrel (Etanercept)

Anti-Infectives

Zavicefta (Ceftazidime and Avibactam)

Zyvox (Linezolid)

Rare Diseases

Vyndaqel (Tafamidis)

Note: The product portfolio may change based on local regulatory approvals and commercial strategies. This list represents major therapeutic areas and key products historically or currently associated with Pfizer operations in Taiwan.